Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 30827-99-7 Chemical Structure| 30827-99-7

Structure of AEBSF HCl
CAS No.: 30827-99-7

Chemical Structure| 30827-99-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AEBSF HCl is a irreversible inhibitor of proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.

Synonyms: AEBSF (hydrochloride); AEBSF HCl; Pefabloc SC

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AEBSF HCl

CAS No. :30827-99-7
Formula : C8H11ClFNO2S
M.W : 239.69
SMILES Code : O=S(C1=CC=C(CCN)C=C1)(F)=O.[H]Cl
Synonyms :
AEBSF (hydrochloride); AEBSF HCl; Pefabloc SC
MDL No. :MFCD00132962
InChI Key :WRDABNWSWOHGMS-UHFFFAOYSA-N
Pubchem ID :186136

Safety of AEBSF HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H314
Precautionary Statements:P260-P280-P303+P361+P353-P301+P330+P331-P304+P340+P310-P305+P351+P338+P310
Class:8
UN#:3261
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Neutrophils 1 mM 1 hour Inhibition of IL-1β secretion Front Immunol. 2018 Feb 19;9:269.
Human umbilical vein endothelial cells (HUVEC) 1 mg/ml 1 hour Evaluate the uptake of PG-AF in HUVEC, showing that PG-AF accumulates in cells while free AF does not. Int J Nanomedicine. 2017 Jan 13;12:577-591.
Human plasma 100 µg/mL 120 seconds To assess the effect of AEBSF on the direct fibrinogen cleaving actions of C. mictlantecuhtli venom, results showed that AEBSF inhibited this action. Front Immunol. 2021 Mar 11;12:612846.
Mono Mac 6 (MM6) cells 150 to 250 µM 18 hours AEBSF blocked Dicer proteolysis, resulting in increased full-length Dicer and decreased 170 kDa and 50 kDa fragments. Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8573-8583.
Human primary monocytes 250 µM 18 hours AEBSF treatment resulted in strong up-regulation of full-length Dicer and reduced the 50 kDa fragment. Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8573-8583.
Human retinal pigment epithelial cells (hRPE) 0-300 µM 2 hours Pretreatment with AEBSF significantly inhibited TM-induced mitochondrial permeability transition and cell death in hRPE cells Free Radic Biol Med. 2012 Sep 1;53(5):1111-22.
Keratinocytes 250 µM 20 hours AEBSF significantly inhibited TLSP activity in the stratum corneum. J Invest Dermatol. 2012 May;132(5):1435-42.
Uni-Graft prosthesis 0.6 mg/mL 3 hours Inhibition of adhesion and multiplication of Staphylococcus aureus and Candida albicans Biomolecules. 2020 Jan 4;10(1):82.
Human Umbilical Vein Endothelial Cells (HUVEC) 100 µM 4 hours AEBSF inhibited the ATF6 signaling pathway, blocking the sFRP2-mediated angiogenesis through cTGF, resulting in reduced tubule formation in HUVECs. Basic Res Cardiol. 2020 Jun 26;115(4):48.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SFRP2 TG mice Permanent Coronary Artery Occlusion Model Osmotic Pump 2 μg/kg/day Once daily for 1 week AEBSF, by inhibiting the ATF6 signaling pathway, blocked the sFRP2-mediated cardioprotection and angiogenesis, resulting in the abolition of reduced infarct size and protection of cardiac function. Basic Res Cardiol. 2020 Jun 26;115(4):48.
Mice IL10-/- mice Oral gavage 300 mg/kg Starting from 1 day before V/M treatment and continuing during V/M treatment To assess the effect of AEBSF on V/M-induced high protease activity and intestinal barrier function, results showed that AEBSF significantly reduced protease activity and protected intestinal barrier function. Cell Mol Gastroenterol Hepatol. 2018 May 29;6(3):370-388.e3

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.17mL

0.83mL

0.42mL

20.86mL

4.17mL

2.09mL

41.72mL

8.34mL

4.17mL

References

 

Historical Records

Categories